Concepedia

Siegfried Goldmann

SG

Statistics

Publications

19

Citations

1.8K

H-Index

16

Active since

1978

Affiliations

Bayer (Germany)(Current)

HEC Pharm (China)

South China University of Technology

Guangzhou Institutes of Biomedicine and Health

Chinese Academy of Sciences

Siegfried Goldmann is an author at Bayer (Germany) specializing in medicinal chemistry, pharmacology, and life sciences.

ORCID

Publications per year

1978–2019

19

Publications

19

Inhibition of Hepatitis B Virus Replication by Drug-Induced Depletion of Nucleocapsids

Karl Deres, Claus H. Schröder, Arnold Paessens et al. · Science · 2003 · 506 citations

, , +17

1,4‐Dihydropyridines: Effects of Chirality and Conformation on the Calcium Antagonist and Calcium Agonist Activities

Siegfried Goldmann, Jürgen Stoltefuß · Angewandte Chemie International Edition in English · 1991 · 454 citations

, , +7

Inhibition of human hepatitis B virus (HBV) by a novel non-nucleosidic compound in a transgenic mouse model

Olaf Weber, K.-H. Schlemmer, Enno Hartmann et al. · Antiviral Research · 2002 · 162 citations

, , +9

Preclinical Characterization of GLS4, an Inhibitor of Hepatitis B Virus Core Particle Assembly

Guoyi Wu, Bo Liu, Yingjun Zhang et al. · Antimicrobial Agents and Chemotherapy · 2013 · 122 citations · Full text

, , +12

Determination of the absolute configuration of the active amlodipine enantiomer as (-)-S: a correction

Siegfried Goldmann, Juergen Stoltefuss, Liborius Born · Journal of Medicinal Chemistry · 1992 · 86 citations

, , +8

1–5 of 19